论文部分内容阅读
目的讨论研究在小儿感染性腹泻时应用思密达治疗的实际临床效果,为今后临床小儿感染性腹泻的治疗提供参考和指导。方法将74例小儿感染性腹泻患者随机平均分为实验组和对照组,对照组采用抗生素抗感染、补液等基础治疗方法,实验组在对照组的基础上加用思密达,治疗一段时间后观察两组患儿的治疗效果。结果实验组患儿治疗效果明显好于对照组患儿。实验组患儿中32例有效,有效率为86.49%;对照组患儿中25例有效,有效率为67.57%。结论通过对比发现实验组患儿的治疗效果明显优于对照组患儿,因此运用思密达治疗小儿感染性腹泻时可以显著提高疗效,在临床值得使用和推广。
Objective To study the clinical effect of applying Smecta in children with infectious diarrhea and to provide reference and guidance for the future clinical treatment of infectious diarrhea in children. Methods A total of 74 cases of children with infectious diarrhea were randomly divided into experimental group and control group. The control group was treated with antibiotics such as anti-infective and fluid replacement. The experimental group was treated with metamizumab on the basis of the control group. After treatment for a period of time To observe the treatment effect of two groups of children. Results The therapeutic effect of experimental group was obviously better than that of control group. 32 cases in the experimental group were effective, the effective rate was 86.49%; 25 cases in the control group were effective, the effective rate was 67.57%. Conclusion Through the comparison found that the experimental group of children with treatment was significantly better than the control group of children, therefore the use of Smecta treatment of pediatric infectious diarrhea can significantly improve the efficacy of the clinical worth using and promotion.